Black Bird Biotech, Inc. (BBBT) Stock

About Black Bird Biotech, Inc.

Black Bird Biotech Inc. operates within the biotechnology sector, offering a diverse array of products. A key offering is MiteXstream, a unique plant-derived biopesticide manufactured and distributed by the company, specifically formulated to eradicate spider mites. The company further diversifies its portfolio with a range of consumer goods sold under its Grizzly Creek Naturals brand. These include CBD oils, gummies, and pet treats, as well as CBD-infused personal care items and both gel and spray hand sanitizer products. Beyond these offerings, Black Bird Biotech also engages in the cultivation of industrial hemp, participating in the Montana Hemp pilot program. The entity, headquartered in Flower Mound, Texas, underwent a name change in June 2021, transitioning from its former identity as Digital Development Partners, Inc. to its current Black Bird Biotech, Inc. designation.

Black Bird Biotech, Inc. (BBBT) stock trades at $0.00 with a market capitalization of $98405. The stock is valued at a price-to-earnings (P/E) ratio of -0.02, price-to-book of -0.05, price-to-sales of 4.92. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Black Bird Biotech, Inc. generates a return on equity (ROE) of 200.00% — well above the market average, a sign of a high-quality business, return on capital employed of 198.15%, an operating margin of -276.45%, a net profit margin of 0.00%.

Official website: blackbirdbiotech.com